Mary C Whitman, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oculomotor Muscles | 11 | 2024 | 404 | 2.780 |
Why?
|
Strabismus | 6 | 2025 | 320 | 2.190 |
Why?
|
Esotropia | 4 | 2024 | 99 | 2.060 |
Why?
|
Ophthalmoplegia | 5 | 2024 | 168 | 1.700 |
Why?
|
Exotropia | 2 | 2024 | 64 | 1.580 |
Why?
|
Oculomotor Nerve | 4 | 2019 | 72 | 1.550 |
Why?
|
Tubulin | 5 | 2021 | 694 | 1.340 |
Why?
|
Synkinesis | 2 | 2019 | 23 | 1.270 |
Why?
|
Fibrosis | 4 | 2021 | 2073 | 0.980 |
Why?
|
Neuromuscular Junction | 2 | 2024 | 399 | 0.920 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2025 | 378 | 0.880 |
Why?
|
Axons | 6 | 2021 | 1677 | 0.790 |
Why?
|
Microscopy, Confocal | 4 | 2024 | 1967 | 0.770 |
Why?
|
Acrocephalosyndactylia | 1 | 2022 | 93 | 0.770 |
Why?
|
Nystagmus, Pathologic | 1 | 2022 | 104 | 0.760 |
Why?
|
Facial Paralysis | 2 | 2023 | 346 | 0.730 |
Why?
|
Cranial Nerve Diseases | 1 | 2021 | 111 | 0.710 |
Why?
|
Depth Perception | 2 | 2022 | 94 | 0.690 |
Why?
|
Organ Culture Techniques | 2 | 2019 | 788 | 0.680 |
Why?
|
Receptors, CXCR | 1 | 2019 | 52 | 0.650 |
Why?
|
Homozygote | 1 | 2024 | 1774 | 0.650 |
Why?
|
Olfactory Pathways | 3 | 2009 | 131 | 0.640 |
Why?
|
Olfactory Bulb | 4 | 2008 | 198 | 0.610 |
Why?
|
Time-Lapse Imaging | 1 | 2019 | 194 | 0.600 |
Why?
|
Eye Diseases, Hereditary | 2 | 2017 | 124 | 0.600 |
Why?
|
Malformations of Cortical Development | 2 | 2021 | 174 | 0.590 |
Why?
|
Craniosynostoses | 1 | 2022 | 415 | 0.590 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2018 | 53 | 0.590 |
Why?
|
Eye Movements | 4 | 2024 | 510 | 0.560 |
Why?
|
Motor Neurons | 6 | 2023 | 871 | 0.560 |
Why?
|
Receptors, CXCR4 | 2 | 2019 | 729 | 0.550 |
Why?
|
Accommodation, Ocular | 2 | 2018 | 47 | 0.540 |
Why?
|
Duane Retraction Syndrome | 1 | 2017 | 59 | 0.540 |
Why?
|
Chemokine CXCL12 | 1 | 2018 | 455 | 0.530 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2021 | 713 | 0.500 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2043 | 0.500 |
Why?
|
Vision, Binocular | 2 | 2016 | 225 | 0.470 |
Why?
|
Eyeglasses | 1 | 2016 | 138 | 0.470 |
Why?
|
Neurons | 6 | 2025 | 9521 | 0.440 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2025 | 1884 | 0.420 |
Why?
|
Lens Implantation, Intraocular | 1 | 2014 | 192 | 0.410 |
Why?
|
Forehead | 1 | 2012 | 75 | 0.400 |
Why?
|
Skull Neoplasms | 1 | 2012 | 173 | 0.380 |
Why?
|
Cataract Extraction | 2 | 2020 | 464 | 0.370 |
Why?
|
Psychomotor Performance | 1 | 2019 | 1885 | 0.370 |
Why?
|
Amino Acid Substitution | 4 | 2021 | 1742 | 0.360 |
Why?
|
Iliac Vein | 1 | 2011 | 71 | 0.360 |
Why?
|
Green Fluorescent Proteins | 5 | 2019 | 2062 | 0.350 |
Why?
|
Orbital Neoplasms | 1 | 2012 | 222 | 0.350 |
Why?
|
Cell Differentiation | 4 | 2025 | 11642 | 0.340 |
Why?
|
Ocular Motility Disorders | 2 | 2024 | 144 | 0.330 |
Why?
|
Motor Activity | 1 | 2019 | 2711 | 0.330 |
Why?
|
Iliac Artery | 1 | 2011 | 344 | 0.320 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4960 | 0.320 |
Why?
|
Cataract | 1 | 2014 | 837 | 0.300 |
Why?
|
Lymphoma, Follicular | 1 | 2012 | 459 | 0.300 |
Why?
|
Mutation | 6 | 2021 | 30210 | 0.300 |
Why?
|
Dendrites | 2 | 2007 | 469 | 0.290 |
Why?
|
Adult Stem Cells | 1 | 2009 | 221 | 0.280 |
Why?
|
Cerebral Ventricles | 1 | 2009 | 550 | 0.270 |
Why?
|
Mice | 20 | 2024 | 81838 | 0.260 |
Why?
|
H-2 Antigens | 3 | 2001 | 359 | 0.250 |
Why?
|
beta 2-Microglobulin | 3 | 2001 | 330 | 0.250 |
Why?
|
Vascular Malformations | 1 | 2011 | 470 | 0.240 |
Why?
|
Neurogenesis | 2 | 2023 | 864 | 0.240 |
Why?
|
Chromosome Duplication | 1 | 2025 | 79 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18075 | 0.220 |
Why?
|
Cell Movement | 5 | 2019 | 5194 | 0.210 |
Why?
|
Myosin Heavy Chains | 1 | 2024 | 403 | 0.200 |
Why?
|
Animals | 22 | 2024 | 168801 | 0.200 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1321 | 0.180 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11035 | 0.180 |
Why?
|
Histidine | 1 | 2021 | 301 | 0.180 |
Why?
|
Syndrome | 2 | 2021 | 3270 | 0.180 |
Why?
|
Animals, Newborn | 3 | 2024 | 2677 | 0.170 |
Why?
|
Neural Crest | 1 | 2022 | 277 | 0.170 |
Why?
|
Trochlear Nerve | 1 | 2019 | 26 | 0.170 |
Why?
|
Pedigree | 2 | 2019 | 4535 | 0.170 |
Why?
|
Axotomy | 1 | 2019 | 71 | 0.160 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1305 | 0.160 |
Why?
|
Gene Duplication | 1 | 2020 | 316 | 0.160 |
Why?
|
Synapses | 2 | 2008 | 1759 | 0.160 |
Why?
|
Facial Muscles | 1 | 2019 | 159 | 0.160 |
Why?
|
Child | 10 | 2024 | 80567 | 0.150 |
Why?
|
Eye | 1 | 2022 | 710 | 0.150 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22339 | 0.150 |
Why?
|
Arginine | 1 | 2021 | 931 | 0.150 |
Why?
|
Benzylamines | 1 | 2018 | 251 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4423 | 0.140 |
Why?
|
Genotype | 2 | 2024 | 13027 | 0.140 |
Why?
|
Eye Injuries | 1 | 2020 | 228 | 0.140 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2596 | 0.140 |
Why?
|
Culture Media | 1 | 2019 | 889 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 970 | 0.130 |
Why?
|
Child, Preschool | 7 | 2021 | 42509 | 0.130 |
Why?
|
Amino Acid Sequence | 3 | 2019 | 13400 | 0.130 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9540 | 0.130 |
Why?
|
Humans | 26 | 2025 | 766019 | 0.130 |
Why?
|
Signal Transduction | 2 | 2018 | 23600 | 0.130 |
Why?
|
Orbit | 1 | 2019 | 458 | 0.130 |
Why?
|
Genetic Counseling | 1 | 2019 | 634 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2469 | 0.120 |
Why?
|
In Situ Hybridization | 1 | 2018 | 1885 | 0.120 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1562 | 0.120 |
Why?
|
Female | 19 | 2024 | 396174 | 0.110 |
Why?
|
Aphakia, Postcataract | 1 | 2014 | 51 | 0.110 |
Why?
|
Nerve Regeneration | 2 | 2018 | 801 | 0.110 |
Why?
|
Abnormalities, Multiple | 1 | 2021 | 1424 | 0.110 |
Why?
|
Genetic Linkage | 1 | 2019 | 2342 | 0.110 |
Why?
|
Embryo, Mammalian | 1 | 2019 | 1674 | 0.110 |
Why?
|
Protein Transport | 1 | 2019 | 1939 | 0.110 |
Why?
|
Eye Diseases | 1 | 2019 | 660 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2018 | 1715 | 0.110 |
Why?
|
Gene Frequency | 1 | 2020 | 3623 | 0.110 |
Why?
|
Retinal Artery Occlusion | 1 | 2014 | 82 | 0.110 |
Why?
|
Phenotype | 3 | 2024 | 16714 | 0.100 |
Why?
|
Mastectomy, Radical | 1 | 2012 | 19 | 0.100 |
Why?
|
Skull | 1 | 2017 | 818 | 0.100 |
Why?
|
Infant | 3 | 2021 | 36424 | 0.100 |
Why?
|
Ophthalmology | 1 | 2019 | 559 | 0.100 |
Why?
|
Young Adult | 6 | 2024 | 59858 | 0.100 |
Why?
|
Congenital Abnormalities | 1 | 2017 | 703 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2021 | 2590 | 0.100 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18321 | 0.090 |
Why?
|
Endophthalmitis | 1 | 2014 | 263 | 0.090 |
Why?
|
Spinal Cord | 1 | 2019 | 1811 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2743 | 0.090 |
Why?
|
Male | 14 | 2024 | 363880 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6057 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4112 | 0.090 |
Why?
|
Retinal Neovascularization | 1 | 2014 | 286 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2019 | 9600 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.080 |
Why?
|
Transcription Factors | 2 | 2019 | 12128 | 0.080 |
Why?
|
Phlebography | 1 | 2011 | 326 | 0.080 |
Why?
|
Mental Health | 1 | 2024 | 3272 | 0.080 |
Why?
|
Isotretinoin | 1 | 2011 | 135 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16040 | 0.080 |
Why?
|
Adolescent | 7 | 2024 | 88808 | 0.080 |
Why?
|
Adult | 7 | 2024 | 223110 | 0.080 |
Why?
|
Corneal Diseases | 1 | 2014 | 535 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2014 | 702 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6892 | 0.080 |
Why?
|
Angioplasty | 1 | 2011 | 353 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1152 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17597 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 1777 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3955 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9351 | 0.070 |
Why?
|
Intermediate Filament Proteins | 1 | 2007 | 261 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2009 | 354 | 0.070 |
Why?
|
Glutamate Decarboxylase | 1 | 2007 | 239 | 0.070 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2007 | 367 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2009 | 2543 | 0.060 |
Why?
|
Visual Acuity | 1 | 2016 | 2672 | 0.060 |
Why?
|
Genetic Testing | 1 | 2019 | 3592 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26280 | 0.060 |
Why?
|
Steroids | 1 | 2011 | 934 | 0.060 |
Why?
|
Parvalbumins | 1 | 2007 | 256 | 0.060 |
Why?
|
Brain | 2 | 2009 | 27175 | 0.060 |
Why?
|
Cell Count | 1 | 2009 | 1825 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 22230 | 0.060 |
Why?
|
Stem Cells | 3 | 2007 | 3537 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21072 | 0.060 |
Why?
|
Suture Techniques | 1 | 2009 | 774 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1769 | 0.060 |
Why?
|
Glaucoma | 1 | 2014 | 1194 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 2242 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3546 | 0.060 |
Why?
|
Cell Death | 1 | 2009 | 1677 | 0.060 |
Why?
|
Cell Lineage | 3 | 2007 | 2574 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5791 | 0.050 |
Why?
|
Binding Sites | 3 | 2021 | 6002 | 0.050 |
Why?
|
Heparin | 1 | 2011 | 1635 | 0.050 |
Why?
|
Neurons, Efferent | 1 | 2023 | 81 | 0.050 |
Why?
|
GATA2 Transcription Factor | 1 | 2023 | 158 | 0.050 |
Why?
|
Isoenzymes | 1 | 2007 | 1688 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4561 | 0.050 |
Why?
|
Interneurons | 1 | 2007 | 593 | 0.050 |
Why?
|
Astrocytes | 1 | 2009 | 1353 | 0.050 |
Why?
|
Antigens, Surface | 2 | 2002 | 1616 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2156 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2022 | 81544 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6208 | 0.050 |
Why?
|
Protein Structure, Quaternary | 1 | 2001 | 423 | 0.040 |
Why?
|
Antigens, Ly | 1 | 2001 | 297 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2009 | 10431 | 0.040 |
Why?
|
Nerve Tissue Proteins | 3 | 2007 | 4399 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2006 | 5756 | 0.040 |
Why?
|
Thermodynamics | 1 | 2001 | 577 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3191 | 0.040 |
Why?
|
Lenses, Intraocular | 1 | 2020 | 141 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 30228 | 0.040 |
Why?
|
Lens, Crystalline | 1 | 2020 | 387 | 0.040 |
Why?
|
HLA Antigens | 1 | 2002 | 1338 | 0.030 |
Why?
|
Epinephrine | 1 | 2020 | 782 | 0.030 |
Why?
|
Models, Animal | 2 | 2017 | 2120 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2019 | 3606 | 0.030 |
Why?
|
Maze Learning | 1 | 2018 | 482 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2001 | 3750 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1748 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1973 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1362 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 2018 | 529 | 0.030 |
Why?
|
Nerve Net | 1 | 2007 | 2306 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1131 | 0.030 |
Why?
|
Anticoagulants | 1 | 2011 | 4854 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2014 | 26379 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2796 | 0.030 |
Why?
|
Protein Binding | 3 | 2001 | 9302 | 0.030 |
Why?
|
T-Box Domain Proteins | 2 | 2006 | 470 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74837 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 41677 | 0.030 |
Why?
|
Microtubules | 1 | 2018 | 1064 | 0.030 |
Why?
|
Transgenes | 2 | 2006 | 1014 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2011 | 39233 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1649 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1623 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7870 | 0.020 |
Why?
|
Action Potentials | 1 | 2018 | 1835 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2019 | 2864 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18382 | 0.020 |
Why?
|
Aged | 4 | 2024 | 171170 | 0.020 |
Why?
|
Dimerization | 2 | 2002 | 881 | 0.020 |
Why?
|
Surface Plasmon Resonance | 2 | 2001 | 268 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 1447 | 0.020 |
Why?
|
Retinal Degeneration | 1 | 2014 | 413 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 24272 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20699 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 2974 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4910 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8723 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1999 | 5503 | 0.020 |
Why?
|
Olfactory Receptor Neurons | 1 | 2008 | 95 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2000 | 5125 | 0.020 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2007 | 133 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15820 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2007 | 3733 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2007 | 165 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1999 | 4408 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9655 | 0.020 |
Why?
|
Receptors, Immunologic | 2 | 2002 | 1416 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7599 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1999 | 4649 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2007 | 839 | 0.010 |
Why?
|
Base Sequence | 2 | 2006 | 12405 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7850 | 0.010 |
Why?
|
Gene Targeting | 1 | 2007 | 840 | 0.010 |
Why?
|
Mental Disorders | 1 | 2024 | 6870 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5739 | 0.010 |
Why?
|
Receptors, KIR2DL4 | 1 | 2002 | 1 | 0.010 |
Why?
|
Tamoxifen | 1 | 2007 | 964 | 0.010 |
Why?
|
Dithiothreitol | 1 | 2002 | 92 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14457 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1525 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1169 | 0.010 |
Why?
|
Cystine | 1 | 2002 | 96 | 0.010 |
Why?
|
Receptors, KIR | 1 | 2002 | 114 | 0.010 |
Why?
|
Choriocarcinoma | 1 | 2002 | 121 | 0.010 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2001 | 30 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily A | 1 | 2001 | 21 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2002 | 433 | 0.010 |
Why?
|
Neuroglia | 1 | 2007 | 963 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2006 | 12772 | 0.010 |
Why?
|
Entropy | 1 | 2001 | 209 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11906 | 0.010 |
Why?
|
Molecular Weight | 1 | 2002 | 2161 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 645 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223035 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59497 | 0.010 |
Why?
|
Reoperation | 1 | 2009 | 4308 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2002 | 620 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12803 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 880 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14065 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1677 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2001 | 592 | 0.010 |
Why?
|
Cysteine | 1 | 2002 | 898 | 0.010 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1999 | 379 | 0.010 |
Why?
|
Protein Folding | 1 | 2001 | 868 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13614 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2002 | 2223 | 0.010 |
Why?
|
United States | 1 | 2024 | 72918 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6101 | 0.010 |
Why?
|
Interleukin-4 | 1 | 1999 | 1149 | 0.010 |
Why?
|
Ligands | 1 | 2001 | 3274 | 0.010 |
Why?
|
Temperature | 1 | 2001 | 2227 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2002 | 1425 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6273 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2001 | 2206 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1999 | 1894 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6492 | 0.010 |
Why?
|
Models, Molecular | 1 | 2001 | 5383 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3399 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4467 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18965 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1999 | 6215 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2009 | 15804 | 0.000 |
Why?
|
Cell Line | 1 | 2001 | 15545 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9237 | 0.000 |
Why?
|